Evaluating new treatment approach for Tourette syndrome
Tourette syndrome, a neurological disorder affecting up to one per cent of the population, is characterised by sudden unwanted and...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Research group
Olia is a PhD candidate with a background in chemistry and biochemistry. She is also familiar with different methods of nanoparticle synthesis. Her project focuses on fabricating a nanocarrier that can cross therapeutic agents through the blood-brain barrier, delivering them to the damaged brain cells and releasing them at the target site in Alzheimer’s disease. She hopes to overcome the difficulty in treating brain disorders and remove concerns about increasing their number worldwide.
Keep informed with our latest updates.
Stay up to date with our latest news and announcements.